BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 692815)

  • 1. Gastrointestinal motility and body weight gain in rats after brain serotonin depletion by 5, 7-dihydroxytryptamine.
    Saller CF; Stricker EM
    Neuropharmacology; 1978 Jul; 17(7):499-506. PubMed ID: 692815
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of body weight changes after selective serotonin depletion with 5,7-dihydroxytryptamine.
    Baez LA; Browning RA; Cusatis M
    Prog Neuropsychopharmacol; 1980; 4(2):123-7. PubMed ID: 7403347
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased tilt-cage activity after serotonin depletion by 5,7-dihydroxytryptamine.
    Mackenzie RG; Hoebel BG; Norelli HC; Trulson ME
    Neuropharmacology; 1978 Nov; 17(11):957-63. PubMed ID: 152872
    [No Abstract]   [Full Text] [Related]  

  • 4. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
    Black RS; Robinson RG
    Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Mueller RA
    J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of the radioactivity in the central nervous system of the developing rat following intracisternal or subcutaneous administration of 14C-5,7-dihydroxytryptamine.
    Sievers J; Baumgarten HG; Klemm HP; Schlossberger HG; Lolova I
    Bibl Anat; 1981; (19):302-7. PubMed ID: 7225075
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of depletion of brain 5-hydroxytryptamine by 5,7-dihydroxytryptamine on ethanol tolerance and dependence in the rat.
    Wood JM
    Psychopharmacology (Berl); 1980 Jan; 67(1):67-72. PubMed ID: 6768080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early postnatal administration of 5,7-DHT: effects on serotonergic neurons and terminals.
    Towle AC; Breese GR; Mueller RA; Coyle S; Lauder JM
    Brain Res; 1984 Sep; 310(1):67-75. PubMed ID: 6383521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat.
    Nelson DL; Herbet A; Bourgoin S; Glowinski J; Hamon M
    Mol Pharmacol; 1978 Nov; 14(6):983-95. PubMed ID: 732817
    [No Abstract]   [Full Text] [Related]  

  • 10. Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat.
    Stewart RM; Campbell A; Sperk G; Baldessarini RJ
    Psychopharmacology (Berl); 1979 Feb; 60(3):281-9. PubMed ID: 108706
    [No Abstract]   [Full Text] [Related]  

  • 11. Alterations in the neurocytotoxicity of 5,7-dihydroxytryptamine by pharmacologic agents in adult and developing rats.
    Breese GR; Mueller RA
    Ann N Y Acad Sci; 1978 Jun; 305():160-74. PubMed ID: 280248
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of [3H]imipramine binding sites in rat brain regions: effect of neonatal 5,7-dihydroxytryptamine treatment.
    Hrdina PD; Pappas BA; Bialik RJ; Ryan CL
    Eur J Pharmacol; 1982 Sep; 83(3-4):343-4. PubMed ID: 7173315
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of central 5,7-dihydroxytryptamine on the medical hypothalamic syndrome in rats.
    Coscina DV
    Ann N Y Acad Sci; 1978 Jun; 305():627-44. PubMed ID: 280259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin depletion by 5,7-dihydroxytryptamine or para-chloroamphetamine does not affect cancer anorexia.
    Chance WT; von Meyenfeldt M; Fischer JE
    Pharmacol Biochem Behav; 1983 Jan; 18(1):115-21. PubMed ID: 6187026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine on the rat central nervous system after intraventricular or intracerebral application and on blood platelets in vitro.
    Da Prada M; Pieri L; Keller HH; Pieri M; Bonetti EP
    Ann N Y Acad Sci; 1978 Jun; 305():595-620. PubMed ID: 152083
    [No Abstract]   [Full Text] [Related]  

  • 16. Facilitation of shock-induced fighting following intraventricular 5,7-dihydroxytryptamine and 6-hydroxydopa.
    Kantak KM; Hegstrand LR; Eichelman B
    Psychopharmacology (Berl); 1981; 74(2):157-60. PubMed ID: 6791220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of 5,7-dihydroxytryptamine on the serum corticosterone resistance to suppression by dexamethasone.
    McIntyre IM; Oxenkrug GF; Stanley M; Gershon S
    Brain Res; 1984 Aug; 309(1):156-8. PubMed ID: 6488005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intraventricular injection of 5,7-dihydroxytryptamine on serum gonadotropins and prolactin.
    Wuttke W; Hancke JL; Höhn KG; Baumgarten HG
    Ann N Y Acad Sci; 1978 Jun; 305():423-36. PubMed ID: 280254
    [No Abstract]   [Full Text] [Related]  

  • 19. Sexual behavior in male rats after intracerebral injection of 5,7-dihydroxytryptamine.
    Larsson K; Fuxe K; Everitt BJ; Holmgren M; Södersten P
    Brain Res; 1978 Feb; 141(2):293-303. PubMed ID: 626904
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of intraventricular injection of 5,7-dihydroxytryptamine on monoamines and sleep in the kitten (author's transl)].
    Adrien J; Bourgoin S; Laguzzi R; Hamon M
    J Physiol (Paris); 1981; 77(2-3):425-30. PubMed ID: 7288656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.